Article

Comprehensive profiling the immune-status of a broad range of in vivo syngeneic models to support IO development and to accurately predict clinical benefit of therapy

2023-09-19

Abstract excerpt

Latterly with approval of PD-1, PD-L1 antibodies in clinical oncology, immunotherapy has gained recognition for changing the way of cancer treatment by joining chemotherapy, radiation and surgery. Murine syngeneic tumor models are critical to novel immuno-based therapy development. Therefore, understood the nature immune status and tumor microenvironment of in vivo tumor models is very important to assist explorin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c57f0b72-4351-5d36-9ff4-069da7cb9cd9
DOI: 10.21203/rs.3.rs-3351199/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comprehensive profiling the immune-status of a broad range of in vivo syngeneic models to support IO development and to accurately predict clinical benefit of therapyDOI 10.21203/rs.3.rs-3351199/v1Read

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.Semantic proximity Read

Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy.Semantic proximity Read

Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cells.Semantic proximity Read

Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor ModelsSemantic proximity Read

Molecular and cellular phenotypic differences distinguish murine syngeneic models from human tumorsSemantic proximity Read

Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategiesSemantic proximity Read

The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity.Semantic proximity Read

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read

Autologous humanized mouse models of iPSC-derived tumors allow for the evaluation and modulation of cancer-immune cell interactionsSemantic proximity Read

Engineering the Immune Microenvironment into Organoid ModelsSemantic proximity Read

Humanized patient-derived xenografts preserve tumour-specific immune microenvironmentsSemantic proximity Read

A Self-Assembling Immune-Featured Osteosarcoma Patient/PDX Derived Organoid Model and Biobank for Personalized Immune TherapySemantic proximity Read